NCT00567931View on ClinicalTrials.gov

1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2012

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

1-methyl-d-tryptophan

Given orally

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (2)

23298

Virginia Commonwealth University, Richmond

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00567931 - 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter